Your firm is considering investing in a promising biotechnology startup. The startup is currently valued at $1
Fantastic news! We've Found the answer you've been seeking!
Question:
Your firm is considering investing in a promising biotechnology startup. The startup is currently valued at $1 million today. Based on your analysis, you believe that the startup has a 10% prob- ability of success in which case it will be worth $40 million in 10 years. However, it has a 90% probability of failure in which case the value of your investment will drop to zero. Assume that the startup produces no intermediate net cash flows.
What is the internal rate of return (IRR) of this investment?
Assume a discount rate of 10%. Using the NPV rule, should your firm invest in the biotechnology startup
Related Book For
Taxes And Business Strategy A Planning Approach
ISBN: 9780132752671
5th Edition
Authors: Myron Scholes, Mark Wolfson, Merle Erickson, Michelle Hanlon
Posted Date: